Skip to main content
. 2021 Nov 17;39(52):7554–7561. doi: 10.1016/j.vaccine.2021.11.031

Table 3.

Factors influencing COVID-19 vaccine acceptance.

Factors Thai (n,%) Expat (n,%) P-value
The biggest influence on getting vaccine
Myself 560 (87.9) 220 (68.3) <0.001**
Family member 372 (58.4) 55 (17) <0.001**
Scientist 254 (39.9) 140 (43.5) 0.284
Expert vaccine 414 (65.0) 161 (50.0) <0.001**
Government 78 (12.2) 55 (17.1) 0.041*
Friend or People I work 45 (7.1) 13 (4.0) 0.063
Community 22 (3.5) 20 (6.2) 0.049*
Concerns among responders
Adverse 554 (87.0) 165 (51.2) <0.001**
Vaccine efficacy 392(61.5) 157(48.8) <0.001**
Immunity after vaccine 265 (41.6) 127 (39.4) 0.520
Research on vaccine 205 (32.2) 67 (20.8) <0.001**
Vaccine authorization 112 (17.6) 25 (7.8) <0.001**
Vaccine safety 453 (71.1) 111 (34.5) <0.001**
Vaccine manufacturer 212 (33.3) 156 (48.4) <0.001**
Political involve 144 (22.6) 125 (38.8) <0.001**
Vaccine manufacturer preference
Domestic 39 (6.1) 4 (1.2) <0.001**
Imported 272 (42.7) 176 (54.7)
  • -

    US

236 (87.1) 116 (66.3)
  • -

    UK

25 (9.2) 41(23.4)
  • -

    China

5 (1.8) 1 (0.6)
  • -

    other

5 (1.8) 17 (9.7)
No preference 326 (51.2) 142 (44.1)
Delay vaccination
Yes 358 (56.2) 121 (37.6) <0.001**
  • -

    At least 1 month

116 (32.4) 22 (18.2)
  • -

    At least 3 months

129 (36.0) 47 (38.8)
  • -

    At least 6 months

71 (19.8) 31 (25.6)
  • -

    At least 1 year

42 (11.7) 21 (17.4)
No 146 (22.9) 87 (27.0)
Not sure 133 (20.0) 114 (35.4)
Level of vaccine efficacy
Any level 39 (6.1) 20(6.2) 0.369
At least 30% 1 (0.2) 1 (0.3)
At least 50% 98 (15.4) 36 (11.2)
At least 70% 257 (40.3) 146 (45.3)
At least 90% 242 (38.0) 119 (37.0)
Level of serious side effect
In 10,000 30 (4.7) 32 (9.9) <0.001**
In 100,000 136 (21.4) 112 (34.8)
In 1,000,000 471 (73.9) 178 (55.3)
Level of mild side effect
In 10 94 (14.8) 121 (37.6) <0.001**
In 100 252 (39.6) 103 (32.0)
> 1 in 100 291 (45.7) 98 (30.4)

* P-value < 0.05; ** P-value < 0.01.